Jackie Vanderpuye-Orgle, PhD

Jackie is a Vice President and the Global Head of the Advanced Analytics Unit with experience in conducting empirical research to underscore the differentiated value of assets across a range of therapeutic areas.  In her role at Parexel, Jackie is responsible for providing technical expertise and oversight on network meta-analysis, parametric modelling, predictive analytics, AI, and general statistical analysis workstreams. She focuses on identifying fit-for-purpose analytic solutions to leverage both clinical trial and real-world data to bring the right treatment to the right patient at the right time.

Work experience

Jackie is a health economist with over 20 years of progressive experience in the application of econometric principles and statistical analysis to both clinical and real-world data.  Prior to joining Parexel, she worked as a Senior Manager in Global Health Economics at Amgen. Jackie also worked as a Director of Research Operations and Senior Economist at Precision Health Economics where she was responsible for developing proposals and executing projects on several oncology and immune-oncology assets to support regulatory approval, value messaging, and market access in various regions.  In addition, Jackie has held research and consulting roles at Endurance Reinsurance, Analysis Group, and the Public Economics and Macroeconomics Divisions of the World Bank in Washington DC.  She is currently Chair of the ISPOR Biosimilars Special Interest Group.

Education

Jackie completed her PhD at Cornell University following a pre-doctoral in economics at Yale University.